Panel, Hearing
The Future of Brain Health
- Actionable recommendations aim to improve brain health and reduce disparities immediately, while the panel remains committed to finding a cure for Alzheimer's disease despite expectations that a full cure may not be possible by 2025.
- Early prediction and detection are identified as primary strategies, with imminent predictions for blood tests to detect amyloid, alongside future eye tests and driving record analyses to identify significant cognitive impairment.
- Health systems currently deemed unready for neurodegenerative challenges are targeted for transformation into age-friendly models that support care in patients' own environments, utilizing a digital revolution and innovative payment models like home stabilization.
- Research funding and public-private partnerships are expected to drive investigations into viruses, neuroinflammation, and the multifactorial nature of the disease, with state-of-the-science reviews and impact labs scheduled for release and activity in the near future.
- Specific interventions include early detection of amyloid plaques to enable actionable intervention, potential manipulation of brainwave patterns to clear toxic substances, and clinical trials focused on sleep, exercise, and diet.
- Sleep is highlighted as a critical modifiable risk factor, with epidemiologic data indicating lowest health risks for seven hours of nightly sleep and evidence linking sleep disturbances in individuals in their late 50s and early 60s to increased amyloid and tau deposition.
- Demographic factors such as gender, perimenopause, and high school start times are projected to influence precision medicine approaches and adolescent brain health, with sleep deprivation noted to have cumulative negative effects on brain function.
- Clinical trial results regarding pre-symptomatic populations and neuroinflammatory drugs are anticipated in the very near future, with expectations that proof for non-pharmacological interventions will emerge over the next few years.
- Infrastructure challenges for administering new drugs are anticipated, requiring new systems for infusions, while a movement to determine effective healthcare spending is expected to address affordability crises.
- Risks associated with deviations from optimal sleep, including increased risks of depression, anxiety, substance abuse, and Alzheimer's pathology, are noted as significantly affecting women and those with insomnia.
- The field expects a resurgence of interest in viral targets and a deeper understanding of neurodegenerative complexities, building on the premise that interventions beneficial for heart health also support brain health.
- Caregivers and communities are targeted for training and increased understanding to ensure the right care is delivered at the right time, with a focus on making workplaces and neighborhoods more inclusive.